Introduction {#s1}
============

*Campylobacter jejuni* remains a leading bacterial cause of gastroenteritis, with an estimated annual incidence of 2.4 million cases per year in the US (Mead et al., [@B32]), and 400--500 million cases worldwide (Konkel et al., [@B27]; Ruiz-Palacios, [@B42]). Most infections with *C. jejuni* are linked to the consumption of undercooked poultry or foods that have been contaminated with raw poultry (Konkel et al., [@B27]). This is due to the fact that *C. jejuni* is a commensal organism in chickens and is able to colonize the ceca of birds at levels greater than 10^8^ CFU/gram of cecal contents (Sahin et al., [@B43]). Infection with *C. jejuni* (campylobacteriosis) is characterized by diarrhea containing blood and/or leukocytes, fever, and abdominal cramps. Although campylobacteriosis is usually self-limiting, some individuals require antibiotic treatment. Infection with *C. jejuni* can also lead to Guillain--Barré syndrome, an acute demyelinating neuropathy characterized by flaccid paralysis (Konkel et al., [@B27]).

Type III secretion systems (T3SS) are complex macromolecular structures that allow Gram-negative bacteria to secrete proteins across the inner and outer membranes without a periplasmic intermediate (Cornelis, [@B9]; Desvaux et al., [@B10]). Classical T3SS possessed by pathogenic bacteria such as *Yersinia*, *Shigella*, and *Salmonella* allow these organisms to deliver effector proteins from the bacterial cytosol directly to the cytosol of a target human cell (Sory et al., [@B45]; Cornelis, [@B9]; Galan and Wolf-Watz, [@B16]). The delivered effector proteins then modulate host cell behavior to facilitate uptake of the organism and subsequent disease. These classical T3SSs can be described as a "molecular syringe" and are composed of a protein complex spanning both bacterial membranes, which is attached to a needle complex that extends from the cell. The needle complex is a hollow conduit with a tip containing translocon proteins, which incorporate into the membrane of the host cell, allowing for delivery of effector proteins into the host cytosol (Cornelis, [@B9]; Galan and Wolf-Watz, [@B16]).

*C. jejuni*-mediated disease is dependent on many factors, including motility, cell adherence, and cell invasion (Konkel et al., [@B24], [@B27]; Guerry, [@B20]; Flanagan et al., [@B15]). The flagellum, which is a T3SS with components homologous to the classical T3SS, plays a central role in *C. jejuni* pathogenesis. The flagellum is composed of a basal body, hook, and filament. The basal body spans both the inner and outer membranes. The hook is a short, curved conduit extending from the basal body. It is composed primarily of the protein FlgE, and is capped by the hook-filament junction proteins FlgK and FlgL. The components comprising the basal body and hook are assembled as they are exported (Ferris and Minamino, [@B14]). After the hook is completed by the incorporation of FlgK and FlgL, the export specificity of the flagellar T3SS changes to allow for secretion of FlaA and FlaB, which form the flagellar filament (Minamino et al., [@B33]; Ferris and Minamino, [@B14]). Deletion of *flgK, flgL*, or *flgE* abolishes the ability of the organism to form a flagellar filament (Konkel et al., [@B25]; Fernando et al., [@B13]). The flagellar filament is composed of FlaA and FlaB and extends approximately three microns from the bacterial cell (Grant et al., [@B19]; Guerry, [@B20]). The flagellar filament is capped by the FliD protein, which allows flagellin subunits to polymerize into the growing flagellum (Yokoseki et al., [@B51]).

Multiple research groups have concluded that proteins secreted from the flagellum play a role in both commensal colonization of poultry and *C. jejuni* invasion of human epithelial cells (Konkel et al., [@B24]; Ziprin et al., [@B52]; Fernando et al., [@B13]). Proteins found to be exported via the flagellum of *C. jejuni* include CiaB (Konkel et al., [@B24]), CiaC (Christensen et al., [@B7]), CiaI (Buelow et al., [@B5]), FlaC (Song et al., [@B44]), and FspA (Poly et al., [@B38]). The first report of a non-flagellar protein secreted through the *C. jejuni* flagellum was CiaB (Konkel et al., [@B24]). A mutation in the *ciaB* gene abolishes export of the other Cia proteins and reduces bacterial invasion into host cells. Complementation of the *ciaB* mutant restores host cell invasion *in vitro* and virulence *in vivo* (Rivera-Amill et al., [@B41]; Raphael et al., [@B39]). FlaC binds to epithelial cells and is required for maximal cell invasion (Song et al., [@B44]). The FspA protein induces apoptosis of INT 407 cells (Poly et al., [@B38]). Konkel et al. demonstrated that the Cia proteins (i.e., CiaC and CiaI) modulate host cell signaling and alter *C. jejuni* intracellular trafficking (Konkel et al., [@B25]; Christensen et al., [@B7]; Buelow et al., [@B5]; Eucker and Konkel, [@B12]). As one might predict, the *ciaB, ciaC*, and *ciaI* genes up-regulated in response to conditions encountered in the gastrointestinal tract (i.e., bile salt deoxycholate), and have been shown to contain sequences for export through the flagellar T3SS (Malik-Kale et al., [@B31]; Christensen et al., [@B7]). Other research groups have also reported that the expression of *ciaC* and *ciaI* is linked to virulence (Carrillo et al., [@B6]; Stintzi et al., [@B47]). These findings are in agreement with the proposal that the Cia proteins contribute to *C. jejuni* virulence. Interestingly, flagellar proteins can be exported from the classical T3SS and *vice versa* (Lee and Galan, [@B30]; Badea et al., [@B2]). Moreover, proteins exported from the classical T3SS have been reported to ultimately result in the modulation of host cell signaling pathways (Sun et al., [@B48]). In bacteria that possess both flagellar and classical T3SS, the export of proteins is controlled via well-orchestrated gene regulatory mechanisms and chaperone specificity (Lee and Galan, [@B30]). The only T3SS present in *C. jejuni* is the flagellum (Parkhill et al., [@B37]).

*C. jejuni* invasion of host cells is a complex event that is initiated by *C. jejuni* binding to cells via several adhesins, including CadF, FlpA, Cj1349c, and CapA (Konkel et al., [@B23]; Ashgar et al., [@B1]; Flanagan et al., [@B15]; Konkel et al., [@B26]). While *C. jejuni* binding alone to host cells is sufficient to stimulate host cell signaling pathways, this event in itself is not sufficient to facilitate *C. jejuni* invasion of host cells. We have shown that the Cia proteins, which are synthesized and secreted by *C. jejuni* when co-cultured with epithelial cells, are required for maximal cell invasion (Christensen et al., [@B7]). The observation that chloramphenicol, an inhibitor of bacterial protein synthesis, retards *C. jejuni* invasion is consistent with the hypothesis that the Cia proteins contribute to cell invasion (Konkel and Cieplak, [@B22]; Oelschlaeger et al., [@B36]; Rivera-Amill et al., [@B41]). We propose the Cia proteins participate in cell invasion by triggering cell signaling events necessary for actin cytoskeletal rearrangement. Maximal *C. jejuni* invasion of host cells requires activation of the host cell integrin receptors, components of the focal complex, and Rac1 (Eucker and Konkel, [@B12]; Krause-Gruszczynska et al., [@B28]). Together, these events result in membrane ruffling and bacterial uptake.

The purpose of this study was to elucidate the mechanism of Cia protein delivery to host cells. Upon contact with epithelial cells, *C. jejuni* secrete ∼18 Cia proteins (Larson et al., [@B29]). It is not known if the Cia proteins act on the surface of the epithelial cell or if they are delivered to the cytosol of a target epithelial cell. We chose to use CiaC to investigate the mechanism of Cia protein delivery to host cells (Christensen et al., [@B7]). In this study, we present evidence that supports the hypothesis that CiaC is delivered to the cytosol of host cells by cell-associated bacteria.

Materials and methods {#s2}
=====================

Bacterial strains and culture methods
-------------------------------------

*C. jejuni* wild-type strains F38011 (Raphael et al., [@B40]), 81116 (Black et al., [@B4]), and 81--176 (Black et al., [@B4]) were used in this study. Bacteria were grown on Mueller--Hinton agar plates supplemented with 5% citrated bovine blood (MHB) and in Mueller--Hinton (MH) broth with constant shaking. Deoxycholate was added to a concentration of 0.01% to broths where indicated. The bacteria were incubated in a microaerobic environment (85% N~2~, 10% CO~2~, 5% O~2~), at 37°C. The *C. jejuni* were passaged onto fresh media every 48 h. The *E. coli* Inv-α (Invitrogen) and S17--1 λ-*pir* (Tascon et al., [@B49]) strains were cultured on Luria--Bertani agar plates (LB) or in LB broth with shaking. The cultures were incubated at 37°C in an aerobic environment. All cloning steps were performed in *E. coli* TOP10 (Invitrogen), and the ACD fusion vectors were transformed into *E. coli* S-17 for conjugation into *C. jejuni*.

Cell culture
------------

INT 407 cells (ATCC \#CCL-6) were grown in Minimal Essential Medium (MEM; Cellgro) supplemented with 10% fetal bovine serum (FBS; Hyclone Laboratories), 1% glutamine (Invitrogen), and 1% sodium pyruvate (Cellgro). Cultures were maintained at 37°C in a humidified 5% CO~2~ incubator. Cells were grown to confluency and passaged using 2.5% trypsin (Sigma). For ACD delivery assays, a 24-well plate was seeded with 1.5 × 10^5^ cells/well 18 h prior to infection.

Generation of *C. jejuni* mutants
---------------------------------

The *C. jejuni* F38011 *fliD, flaAflaB, fliD, ciaC*, and *ciaB* mutants were generated as previously described (Konkel et al., [@B24], [@B25]; Christensen et al., [@B7]; Buelow et al., [@B5]). The *C. jejuni* F38011 *flgL*, F38011 *flgK*, F38011 *flgE*, 81116 *flaAflaB*, and 81--176 *flaAflaB* mutants were generated by double-crossover recombination using the pBSK-Kan2 suicide vector. The pBSK-Kan2 plasmid is identical to the pBluescript vector (Stratagene), except that the original ampicillin resistance cassette was replaced with the *apha-3* kanamycin resistance cassette, which functions in both *E. coli* and *C. jejuni* (Christensen et al., [@B7]). Approximately 1 kilobase of DNA flanking the target genes was amplified by PCR using the primers indicated in Table [A1](#TA1){ref-type="table"} and sequentially cloned into pBSK-Kan2 using SacI and SacII sites for the upstream fragment and SacII and XhoI sites for the downstream fragments. A tetracycline (Tet) resistance cassette was amplified using the primers indicated in Table [A1](#TA1){ref-type="table"} and inserted into the SacII site between the two flanking regions. The suicide vectors were introduced into *C. jejuni* via electroporation, and transformants were selected for on MHB plates supplemented with 2 μg/mL Tet. The suicide vectors described in this study were confirmed by nucleotide sequencing. Inactivation of the target genes in *C. jejuni* was confirmed by PCR (not shown).

The *flgL* mutant was complemented by PCR amplifying the native promoter and ORF using the primers listed in Table [A1](#TA1){ref-type="table"}, and cloning the PCR product into the pRY111 vector using XhoI and EcoRI. The *flgL* complementation plasmid was electroporated into *E. coli* S-17, and subsequently conjugated into the *C. jejuni* F38011 *flgL* mutant.

Motility assays
---------------

Overnight cultures of *C. jejuni* were harvested from MHB agar plates and re-suspended in MH broth to 1.0 OD~540~/mL. Ten μL of the bacterial suspension was spotted onto the center of a MH agar plate containing only 0.4% agar, and incubated for 48 h. The zone of motility was measured from the edge of the inoculum spot to the edge of growth. Each sample was assayed in triplicate. A separate motility plate was stab-inoculated with each strain for visual comparison of motility zones.

Transmission electron microscopy
--------------------------------

Transmission electron microscopy was performed as previously described (Neal-Mckinney et al., [@B35]). Briefly, *C. jejuni* taken from MHB plates were re-suspended in water, added to formvar coated copper grids, and stained with 2% phosphotungstic acid. The grids were visualized using a FEI Tecnai G2 20 Twin microscope.

Cia secretion assay
-------------------

Secretion of the Cia proteins into culture supernatants was assayed as previously described, with minor modifications (Konkel et al., [@B25]). Briefly, *C. jejuni* grown on MHB agar plates overnight were harvested and washed three times in MEM without methionine or FBS (Cellgro). Three mL of a 0.3 OD~540~/mL suspension was added to a T25 flask, followed by 10 μL of Express Protein Labeling Mix \[β−^35^S\]-methionine (Perkin Elmer) and 30 μL of dialyzed FBS, and incubated for 3 h at 37°C in a 5% CO~2~ incubator. After incubation, 1.5 mL of culture was centrifuged for 5 min in a benchtop centrifuge, and 1 mL of supernatant was filtered through a 0.2 μm filter and transferred to a new tube. The proteins in the supernatant were precipitated using 1 mM HCl-acetone and re-suspended in 100 μL (10-fold concentration). Concentrated supernatants were diluted 1:2 in 2X sample buffer, boiled, and separated by SDS-PAGE. The proteins were transferred to a PVDF membrane and dried overnight. The PVDF membrane was exposed to X-ray film (Kodak Biomax) for 48 h and developed. The secretion assay was repeated at least three times, and a representative image is shown.

Generation of adenylate cyclase domain fusion vectors
-----------------------------------------------------

The ACD (amino-terminus) of *Bordetella pertussis cyaA* was PCR amplified from the pJB2581 vector (Bardill et al., [@B3]), using the primers shown in Table [A1](#TA1){ref-type="table"} and cloned into the pRY111 vector using BglII and KpnI. Inverse PCR was then performed using the primers indicated in Table [A1](#TA1){ref-type="table"}, to create a SacI-PstI-XhoI-BamHI-EcoRI-BglII multiple cloning site immediately upstream of the ACD to create the pRY111-ACD vector. The nucleotide sequences of *ciaC, ciaI, flaA, flaG, flgB*, and *metK* were amplified without the termination codon, using the primers shown in Table [A1](#TA1){ref-type="table"} and cloned into pRY111-ACD using SacI and EcoRI. The vectors were sequenced, and electroporated into *E. coli* S-17 for conjugation into *C. jejuni*.

Adenylate cyclase domain immunoblots
------------------------------------

Immunoblots were performed to detect ACD fusion proteins in whole-cell lysates (WCL) of *C. jejuni*. Bacteria were harvested after overnight growth in MH broth supplemented with 0.01% deoxycholate and suspended in PBS to a density of 10 OD~540~/mL, diluted 1:2 in 2X sample buffer, boiled, and separated by SDS-PAGE. The proteins were transferred to PVDF membranes and probed with a 1:1000 dilution of a mouse anti-ACD antibody (sc-13582, Santa Cruz Biotechnology). Bound mouse antibody was detected using 1:2000 diluted rabbit anti-mouse IgG conjugated to HRP (Sigma), and the blot was developed using Western Lightning ECL reagent (Perkin Elmer).

Adenylate cyclase domain reporter delivery assays
-------------------------------------------------

INT 407 epithelial cells were seeded at a density of 1.5 × 10^5^. *C. jejuni* were grown for 18 h in MH broth supplemented with 0.01% DOC, and harvested by centrifugation. The pellets were re-suspended and washed twice in PBS, then pelleted and re-suspended to a density of 0.3 OD~540~/mL in MEM with 1% FBS. The cell suspension was diluted 1:20, and one mL of the diluted suspension was used to infect a well of INT 407 cells in a 24-well plate. After incubation at 37°C in a humidified 5% CO~2~ incubator for 30 min, the cells were rinsed with PBS, and 300 μL of 0.1 M HCl was added to each well. The INT 407 cells were lysed by incubating the sealed 24-well plate atop boiling water for 15 min, and the lysates were collected. After centrifugation at 16,000 × *g* for 2 min to pellet cell debris, 100 μL of each sample was assayed for cAMP using an enzyme-linked immunosorbant assay cAMP kit (Enzo, New York, NY) according to the manufacturer\'s instructions. Each sample was tested in triplicate. The assays were performed at least three times to ensure reproducibility.

Supernatants from a *C. jejuni* wild-type strain harboring *ciaC-ACD* were collected by inoculating the strain to 0.6 OD~540~/mL in MEM with 1% FBS, and incubating for 1 h. The cultures were centrifuged and supernatants filtered through a 0.2 μm filter to remove any *C. jejuni*. The presence of CiaC-ACD in the supernatants was confirmed using an *in vitro* ACD activity assay and immunoblotting (not shown). For assays using a filter to block contact with host cells, a 6-well tissue culture plate was seeded with 3 × 10^5^ cells/well and incubated overnight. The culture media was replaced with MEM with 1% FBS, and a Thincert (Greiner Bio-One) well insert with a 0.2 μm pore size was added to the wells. Two mL of *C. jejuni* (0.3 OD~540~/mL) in MEM with 1% FBS were used to inoculate the upper chamber of the inserts. TAE226 (Novartis) was dissolved in methanol. For assays using TAE226 to inhibit *C. jejuni* internalization, 10 μM TAE226 was added to the wells of a 24-well plate 30 min prior to infection with *C. jejuni* (0.3 OD~540~/mL). To increase the sensitivity of cAMP detection, we used a high inoculum (0.3 versus 0.015 OD~540~/mL used in the initial assays) in assays using filters to block *C. jejuni* contact with host cells and assays using TAE226 to inhibit invasion. The samples were assayed in triplicate, and the assay was repeated at least three times. A representative assay is shown.

Internalization assay (gentamicin protection assay)
---------------------------------------------------

Binding and internalization assays were performed as described elsewhere (Christensen et al., [@B7]). Briefly, each well of a 24-well plate was inoculated with MEM 1% FBS containing 0.03 OD~540~/mL of *C. jejuni* wild-type strain harboring pRY107 (kanamycin resistant), *ciaC* mutant (chloramphenicol resistant), or a mixture of the two strains. The concentration of the *ciaC* mutant strain was held constant at 0.03 OD~540~/mL, while increasing ratios (i.e., 1:2, 1:5, 1:10) of the wild-type strain were added. Gentamicin was added to the wells 3 h post-infection at a concentration 250 μg/mL, a concentration that has been shown previously to efficiently kill extracellular bacteria without affecting intracellular bacteria (Monteville et al., [@B34]). INT 407 cell lysates were serially diluted and plated on both MHB Kan and MHB Cm plates to select for the wild-type strain and *ciaC* mutant, respectively. Where indicated, TAE226 was added to cells 30 min prior to infection. Statistical significance was evaluated using a two-tailed Student\'s *t*-test (*P* \< 0.05). The samples were assayed in quadruplicate wells, and the assay was performed four times.

Scanning electron microscopy
----------------------------

Scanning electron microscopy (SEM) was performed to observe membrane ruffling, as described elsewhere (Eucker and Konkel, [@B12]). Two independent, blinded observers quantified the number of INT 407 cells with membrane ruffling in four fields of view at 1000× magnification.

Results {#s3}
=======

Secretion of the Cia proteins requires the flagellar hook
---------------------------------------------------------

Flagellar gene deletions were generated in *C. jejuni* F38011 by homologous recombination, resulting in the deletion of the *fliD, flaAflaB, flgL, flgK*, and *flgE* loci. Motility assays were performed to ensure that the motility phenotypes of the flagellar mutant were in agreement with previously published data (Konkel et al., [@B25]; Fernando et al., [@B13]; Neal-Mckinney et al., [@B35]). Inactivation of the *flaAflaB, flgL, flgK*, or *flgE* loci completely abolished motility compared to the *C. jejuni* F38011 wild-type strain and isogenic *fliD* mutant (Figure [1](#F1){ref-type="fig"}). The reduced motility of the *C. jejuni fliD* mutant in motility agar compared to the *C. jejuni* wild-type strain is in agreement with the hypothesis that FliD helps incorporate exported FlaA and FlaB monomers into the growing flagellar filament. The flagellin monomers can diffuse away from the flagellar filament when the *C. jejuni fliD* mutant is grown in broth, reducing flagellum length, and bacterial motility (Yokoseki et al., [@B51]). Based on the results of the Cia secretion assays (see below), experiments were performed to specifically complement the *flgL* mutant by transforming the mutant with a plasmid harboring a wild-type copy of the gene. In contrast to the *flgL* mutant, motility was restored in the transformed isolate, although not to the same amount as the wild-type strain. This is due possibly to differences in transcriptional regulation of the *flgL* gene in the wild-type strain (chromosomal) and *flgL* complemented strain (multi-copy plasmid). Transmission electron microscopy was used to confirm the results of the motility assays, and revealed that the wild-type strain and *flgL* mutant transformed with the *flgL* plasmid produced complete flagella, while the *flgL* mutant did not produce a flagellar filament (Figure [A1](#FA1){ref-type="fig"}). This finding demonstrates that the phenotype displayed by the mutant was due solely to the absence of the FlgL protein.

![**Motility of the *C. jejuni* flagellar mutants.** Motility assays were performed using *C. jejuni* F38011 wild-type strain, the isogenic *fliD, flaAflaB, flgL, flgK*, and *flgE* mutants, and the *flgL* mutant complemented with *flgL* **(A)**. The table contains zones of motility ± one standard deviation obtained from a quantitative motility assay performed in triplicate. The zone of motility was determined by measuring from the edge of the inoculum spot to the edge of growth. A diagram of the *C. jejuni* flagellum is also included, and was adopted from \[Larson et al. ([@B29])\] **(B)**. OM, outermembrane; CM, cytoplasmic membrane.](fcimb-02-00031-g0001){#F1}

Secretion of the Cia proteins from the *C. jejuni fliD, flaAflaB, flgK, flgL*, and *flgE* mutants was assayed by autoradiography of protein supernatants from *C. jejuni* grown in the presence of 1% FBS to stimulate Cia secretion (Figure [2A](#F2){ref-type="fig"}) (Konkel et al., [@B27], [@B25]). The proteins in the supernatant were concentrated, and probed with antibody reactive against the ACD (Figure [2B](#F2){ref-type="fig"}). Supernatants and whole cell lysates (Figures [2C,D](#F2){ref-type="fig"}, respectively) of each of the isolates were probed with an anti-CysM serum to ensure that bacterial cell lysis was not responsible for the proteins observed in the supernatants by autoradiography. The Cia proteins were secreted from the *fliD* and *flaAflaB* mutants but not the *flgL, flgK*, and *flgE* mutants, as judged by autoradiography. The ∼66 kDa band visible in the *flgL, flgK*, and *flgE* mutant secretion profiles is background from the FBS used to stimulate Cia secretion, and was not observed in samples without 1% FBS (not shown). In agreement with the results of the autoradiograph, CiaC-ACD was detected in the supernatant of the wild-type strain, as well as the *fliD* and flaAB mutants (the *flgL* mutant transformed with the *flgL* plasmid did not contain the *ciaC*-*ACD* gene). Interestingly, the *fliD* and *flaAB* mutants had a more intense secretion profile than wild-type.

![**The Cia proteins are secreted from the *C. jejuni* F38011 wild-type strain and *fliD* and *flaAflaB* mutants, but not *flgL, flgK*, and *flgE* mutants.** The *C. jejuni* F38011 wild-type strain and isogenic *fliD, flaAB, flgL, flgK*, and *flgE* mutants were assayed for secretion of the Cia proteins as well as for secretion of plasmid-encoded CiaC-ACD. Newly synthesized proteins were labeled with \[^35^S\]-methionine and Cia secretion was stimulated by the addition of 1% FBS. Proteins in the supernatants were concentrated 10-fold, separated by SDS-PAGE, transferred to PVDF membranes, and exposed to X-ray film **(A)** or probed with an anti-ACD antibody **(B)**. Faint bands present in all lanes represent bovine serum albumin (66.5 kDa) and degradation products. The molecular mass of the pre-stained protein standards are listed in kDa. Supernatants **(C)** and whole-cell lysates **(D)** were probed with anti-CysM antibody to confirm that cell lysis did not occur.](fcimb-02-00031-g0002){#F2}

The results obtained for the secretion assay performed with the newly generated *C. jejuni* F38011 *flaAflaB* mutant were not consistent with our previous findings using a *C. jejuni* 81116 mutant with a partial *flaAflaB* gene deletion (Grant et al., [@B19]). We regenerated new *C. jejuni* 81116 and 81--176 *flaAflaB* mutants whereby the entire *flaA* and *flaB* ORFs were deleted. All three of the *C. jejuni flaAflaB* mutants (F38011, 81116, and 81--176) were non-motile, and exported the Cia proteins into the supernatants as judged by the secretion assay (Figure [A2](#FA2){ref-type="fig"}).

Based on the results of the secretion assay and the fact that FlgL was the most distal component of the flagellar apparatus that appeared necessary for Cia protein secretion, we tested whether the *flgL* complement strain could secrete the Cia proteins. Complementation of the *flgL* mutant with a plasmid encoding *flgL* restored secretion of the Cia proteins. Based on these data, we concluded that the hook and hook-associated proteins, but not the flagellar filament, are required for Cia protein secretion.

*C. jejuni* CiaC is delivered to host cells
-------------------------------------------

We hypothesized that CiaC, which is a secreted from the flagellar apparatus and required for maximal invasion of host cells, is delivered to the cytosol of epithelial cells. To test this hypothesis, we used the adenylate cyclase domain (ACD) of the *Bordetella pertussis* CyaA protein as a reporter for host cell delivery (Glaser et al., [@B18]; Sory and Cornelis, [@B46]; Sory et al., [@B45]). The ACD, which is activated only in the presence of calmodulin found in eukaryotic cells, catalyzes the production of cAMP from ATP. We generated a pRY111-based (Yao et al., [@B50]) shuttle plasmid whereby a number of *C. jejuni* genes, including *ciaC*, were cloned in-frame with the ACD. As a negative control, the *metK* gene driven from its native promoter was also cloned in-frame with the ACD. The *C. jejuni* MetK protein, which is an S-adenosylmethionine synthetase, is localized in the cytoplasm (Parkhill et al., [@B37]). The *ciaC-ACD* and *metK-ACD* plasmids were introduced into the *C. jejuni* F38011 wild-type strain and isogenic flagellar mutants, and ACD delivery assays were performed.

INT 407 cells were infected at a MOI of ∼500, similar to that used in our gentamicin protection assays. The amount of intracellular cAMP produced by the INT 407 cells was assayed at 30 min post-infection, as preliminary experiments revealed this time-point resulted in the greatest level of cAMP (data not shown). Infection of INT 407 cells with the *C. jejuni* F38011 wild-type strain, *fliD* mutant, and *flaAflaB* mutant harboring *ciaC-ACD* resulted in a significant increase in intracellular cAMP compared to the amount of cAMP produced by cells inoculated with the *flgL, flgK*, and *flgE* mutants harboring *ciaC-ACD* (Figure [3](#F3){ref-type="fig"}). Only minimal levels of cAMP were detected in INT 407 cells inoculated with the *C. jejuni* F38011 wild-type strain and *flgE* mutant harboring *metK-ACD*. Noteworthy is that the delivery of CiaC to INT 407 cells was also demonstrated using MOI of ∼5000 and ∼100, whereas a significant increase in cAMP levels (as compared to the flgE mutant negative control) was not detected in INT 407 cells for MetK regardless of the MOI (data not shown). These results are consistent with the hypothesis that the CiaC protein is delivered to the cytosol of host cells. Further, these results indicate that a flagellar hook and hook-associated proteins (FlgE, FlgK, and FlgL) are required for Cia delivery.

![**The CiaC virulence proteins is delivered to the cytosol of INT 407 cells from the *C. jejuni* F38011 wild-type strain, *fliD* mutant, and *flaAflaB* mutant, but not *flgL, flgK*, and *flgE* mutants.** Delivery of the CiaC-ACD fusion protein from the cytosol of *C. jejuni* to the cytosol of INT 407 cells was assayed in the *C. jejuni* F38011 wild-type strain and isogenic *fliD, flaAflaB, flgL, flgK*, and *flgE* mutants, and delivery of MetK-ACD was assayed in the *C. jejuni* F38011 wild-type strain and *flgE* mutant. The concentration of cAMP within the INT 407 cells was assayed 30 min post-infection. The error bars represent one standard deviation from mean. The asterisk indicates values that are significantly different from the *flgE* mutant harboring *ciaC-ACD* as judged by the Student\'s *t*-test (*P* \< 0.05). Data from two biological replicates were combined.](fcimb-02-00031-g0003){#F3}

*C. jejuni* CiaI is delivered to host cells
-------------------------------------------

Previous studies have suggested that multiple flagellar and Cia proteins are secreted upon cultivation with epithelial cells, some of which function to modulate cell behavior and facilitate pathogenesis (Konkel et al., [@B24]; Christensen et al., [@B7]; Buelow et al., [@B5]). To test whether other flagellar exported proteins are delivered to host cells, the ACD reporter assay was used to examine delivery of a known Cia protein (i.e., CiaI) (Buelow et al., [@B5]), as well as secreted flagellar components (i.e., FlaA, FlaG, and FlgB) (Hendrixson and Dirita, [@B21]; Larson et al., [@B29]; Christensen et al., [@B7]) (Figure [4](#F4){ref-type="fig"}). Each ACD construct was transformed into the *C. jejuni* wild-type strain and *flgE* mutant and assayed for cAMP production in INT 407 cells after 30 min infection. Infection with *C. jejuni* F38011 wild-type harboring *ciaI-ACD* resulted in a significant increase in cAMP, compared to the *flgE* mutant harboring *ciaI-ACD*. The *flaA-ACD, flaG-ACD*, and *flgB*-ACD plasmids in the *C. jejuni* F38011 wild-type strain did not result in an increase in cAMP levels compared to the *flgE* mutant. The CiaI-ACD, FlgB-ACD, FlaA-ACD, and FlaG-ACD proteins were exported, as judged by immunoblot analysis of supernatants using anti-ACD and anti-CysM antibodies (Figure [A3](#FA3){ref-type="fig"}). Collectively, these results demonstrate that the CiaC and CiaI proteins are exported and delivered to host cells in a flagellar T3SS dependent manner. The flagellar proteins FlaA, FlaG, and FlgB are either not delivered to host cells or delivered in low concentrations undetectable by our ACD reporter assay.

![**CiaI is delivered from the *C. jejuni* F38011 wild-type strain to INT 407 cells.** Delivery of the CiaI-ACD, FlaA-ACD, FlaG-ACD, and FlgB-ACD fusion proteins was assayed in the *C. jejuni* F38011 wild-type strain and isogenic *flgE* mutant. INT 407 cells were inoculated with the *C. jejuni* F38011 wild-type strain and *flgE* mutant harboring the various ACD plasmids. The concentration of cAMP within the INT 407 cells was assayed 30 min post-infection. The error bars represent one standard deviation from mean. The asterisk indicates that the amount of cAMP produced in the wild-type strain was significantly greater than the value obtained from the *flgE* mutant, as judged by the Student\'s *t*-test (*P* \< 0.05).](fcimb-02-00031-g0004){#F4}

To ensure that each of the ACD fusion proteins were synthesized at equivalent levels in the *C. jejuni* wild-type strain and *flgE* mutant, whole cell lysates of each strain were probed by immunoblot, using an anti-ACD antibody (Figure [5](#F5){ref-type="fig"}). The intensity of the reactive bands in the wild-type strain and *flgE* mutant were similar, indicating that production of the ACD fusion proteins was not significantly affected by mutation of *flgE*.

![**Immunoblot using anti-ACD antibody reveals equivalent protein synthesis of ACD fusion proteins in *C. jejuni* F38011 wild-type strain and *flgE* mutant.** The amount of ACD fusion proteins produced in the *C. jejuni* F38011 wild-type strain and isogenic *flgE* mutant was examined by immunoblot. Whole cell lysates were prepared from bacteria grown overnight in MH broth supplemented with 0.01% deoxycholate, transferred to PVDF membranes, and probed with an anti-ACD antibody. The molecular mass of the pre-stained protein standards are listed in kDa.](fcimb-02-00031-g0005){#F5}

Protein delivery requires bacteria-host cell contact
----------------------------------------------------

To address whether the Cia proteins are delivered to host cells from outer membrane vesicles released into the culture supernatants from *C. jejuni* or via another mechanism not requiring bacteria-host cell contact, we cultured *C. jejuni* in medium containing 1% FBS for 1 h and then prepared bacterial cell-free supernatants. The purpose of adding FBS to the medium was to stimulate the synthesis and export of the Cia proteins into the supernatants (Rivera-Amill et al., [@B41]). For these assays, *C. jejuni* were suspended in medium at a level that was 40-fold greater (0.6 OD~540~/mL) than used for the previous *C. jejuni*-cell infection assays, in order to increase the amount of Cia proteins in the supernatants. Using this procedure, we were readily able to detect CiaC-ACD in the cell-free supernatant by immunoblots and by an *in vitro* activity assay whereby the supernatants were mixed with activity buffer containing ATP and calmodulin (data not shown). The cell-free supernatant was then added to INT 407 epithelial cells and cAMP levels of the cells were measured after 30 min (Figure [6](#F6){ref-type="fig"}). The results were compared to those obtained for cells infected with a wild-type strain (positive control) or *flgE* mutant (negative control) harboring *ciaC-ACD* (Panel A). No cAMP production was observed in cells treated with CiaC-ACD containing supernatants, indicating that the secreted CiaC-ACD protein was not delivered to the host cell cytosol. An additional experiment was performed using a 0.2 μm pore filter to block physical contact of *C. jejuni* with the epithelial cells (Panel B). The filter used created two chambers within the tissue culture well, a bottom chamber containing the epithelial cells and an apical chamber containing a *C. jejuni* wild-type strain harboring *ciaC-ACD*. While proteins were secreted from *C. jejuni* and entered the bottom chamber, no cAMP production was observed. These results suggest that *C. jejuni* binding to host cells is necessary for CiaC protein delivery.

![**CiaC-ACD delivery into INT 407 cells requires bacteria-host cell contact.** The delivery of CiaC-ACD into INT 407 cells assayed using whole bacteria and CiaC-ACD containing supernatants **(A)**, as well as a filter to block physical contact of bacteria with INT 407 cells **(B)**. **(A)** Cell-free supernatants of *C. jejuni* F38011 wild-type strain and isogenic *flgE* mutant were harvested from bacteria incubated in MEM supplemented with 1% FBS for 1 h. The *C. jejuni* F38011 strain harboring the *ciaC-ACD* plasmid or cell-free supernatants collected from this strain were added to INT 407 cells and cAMP was measured 30 min post-inoculation. **(B)** A delivery assay was performed in the presence and absence of a 0.2 μm pore filter. To accommodate the 0.2 μm pore filter, six-well tissue culture plates (rather than 24-well) were used. The value shown for *C. jejuni* F38011 wild-type strain was normalized by subtracting the background cAMP value obtained for the *flgE* mutant, with or without a 0.2 μm pore filter. The error bars represent one standard deviation from mean. The asterisk indicates the amount of cAMP produced in the wild-type strain was significantly greater than the value obtained from the *flgE* mutant as judged by the Student\'s *t*-test (*P* \< 0.05)](fcimb-02-00031-g0006){#F6}

Cia protein delivery does not require bacterial internalization
---------------------------------------------------------------

It had previously been shown that effector proteins can be exported by pathogens located both inside and outside of the target cell (Coburn et al., [@B8]). To determine whether Cia protein delivery was occurring by cell-associated (bound) bacteria, the delivery of CiaC-ACD to host cells was assayed in the presence of TAE226 to inhibit bacterial invasion (Figure [7](#F7){ref-type="fig"}). TAE226 is a specific inhibitor of Focal Adhesion Kinase, which is required for maximal *C. jejuni* invasion of INT 407 cells (Eucker and Konkel, [@B12]). The viability of INT 407 cells treated with TAE226 or methanol (vehicle control) was assessed using trypan blue (Sigma) staining, and neither treatment affected the viability of the cells (data not shown). Treatment of cells with TAE226 significantly reduced invasion of INT 407 cells by *C. jejuni* to a level below that of the *ciaB* mutant (invasion deficient control) in a dose-dependent manner (Figure [7A](#F7){ref-type="fig"}). The addition of TAE226 did not significantly reduce the level of cAMP produced in response to delivery of CiaC-ACD (Figure [7B](#F7){ref-type="fig"}). These data demonstrate that *C. jejuni* delivers proteins to epithelial cells prior to internalization.

![**CiaC-ACD is delivered into INT 407 cells by extracellular bacteria.** A bacterial invasion assay **(A)** and delivery assay **(B)** were performed in the presence of TAE226, an inhibitor of Focal Adhesion Kinase. Focal adhesion kinase is required for maximal invasion of host cells by *C. jejuni*. **(A)** The gentamicin protection assay was used to determine the number of cells of *C. jejuni* F38011 wild-type strain and its isogenic *ciaB* mutant internalized in the presence of 0, 5, or 10 μM TAE226. Gentamicin was added 3 h post-infection to kill extracellular bacteria. The INT 407 cells were then lysed and the bacteria were enumerated by serial dilution and plating. Shown are the number of cell-associated bacteria (black bars) and internalized bacteria (gray bars). The number of bacteria internalized in the presence of TAE226 was significantly reduced, when compared to *C. jejuni* infected cells in the absence of inhibitor, as judged by the Student\'s *t*-test (*P* \< 0.05). **(B)** Delivery of the CiaC-ACD fusion protein was assayed at 30 min post-infection in the presence of 0 or 10 μM TAE226. The values shown were normalized by subtracting the background cAMP value obtained for the *flgE* mutant (i.e., Cia secretion negative) containing each ACD fusion construct from the values obtained for the wild-type strain. The error bars represent one standard deviation from the mean. The amount of cAMP produced in the presence of TAE226 was not significantly different from the value obtained in the absence of TAE226, as judged by the Student\'s *t*-test (*P* \< 0.05). Cells were treated with methanol (vehicle control), and trypan blue staining was performed to confirm that the solvent used for TAE226 did not affect cell viability (not shown).](fcimb-02-00031-g0007){#F7}

A functional flagellar export apparatus is required for *C. jejuni* to induce membrane ruffling of INT 407 cells
----------------------------------------------------------------------------------------------------------------

Delivery of the Cia virulence proteins modulates signaling pathways in host cells, leading to cytoskeletal rearrangement mediated in part by the Rho GTPase Rac1 (Eucker and Konkel, [@B12]). Rearrangement of the host cell cytoskeleton causes the formation of membrane ruffles that can be visualized and quantified using SEM. We performed SEM of cells infected with the *C. jejuni* F38011 wild-type strain, *flgL* mutant, and *flgL* mutant complemented with *flgL* to confirm that the Cia virulence proteins were delivered to host cells in a flagellar T3SS dependent manner (Figure [8](#F8){ref-type="fig"}). In the absence of bacteria, membrane ruffling was observed in 33.5% (\# of cells examined = 212) of the INT 407 cells examined (Panel H). In contrast, 63.7% (\# of cells examined = 216) of the INT 407 cells infected with the *C. jejuni* wild-type strain exhibited membrane ruffling (Panels A and B). Consistent with our previous findings demonstrating that FlgL is required for CiaC export and delivery, the amount of membrane ruffling observed in cells inoculated with the *flgL* mutant (Panels C and D) was indistinguishable from that of non-infected INT 407 cells (membrane ruffling was observed in 35% of the cells, \# of cells examined = 356), whereas the complemented *flgL* mutant (Panels E and F) caused membrane ruffling in 58.5% of cells (\# of cells examined = 232). The addition of cell-free supernatants containing the Cia proteins to INT 407 cells (Panel G) did not stimulate membrane ruffling (27.3% of cells, \# of cells examined = 157). Importantly, bacteria-host cell contact was promoted by centrifugation of the tissue culture plates to eliminate the effects of motility on adherence. Despite the fact that the *flgL* mutant was in contact with the epithelial cells, contact alone did not appear sufficient to induce membrane ruffling. These results support the hypothesis that the delivery of the Cia proteins induces cytoskeletal rearrangement, and the delivery of the Cia proteins depends on a functional flagellar export apparatus.

![***C. jejuni* F38011 wild-type induces membrane ruffling.** INT 407 cells were infected with the *C. jejuni* F38011 wild-type strain **(A** and **B)**, *flgL* mutant **(C** and **D)**, *flgL* mutant harboring a plasmid containing native *flgL* **(E** and **F)**, cell-free supernatants containing the Cia proteins **(G)**, or were uninfected **(H)**. The cells were fixed and removed at 15 min post-infection, and visualized by SEM at 50,000× **(A, C,** and **E)** and 7000× **(B, D, F, G,** and **H)** magnification.](fcimb-02-00031-g0008){#F8}

A *C. jejuni* wild-type strain cannot rescue the invasion of a *ciaC* mutant
----------------------------------------------------------------------------

As we observed intense membrane ruffling in response to delivery of the Cia proteins, we sought to determine whether the Cia proteins delivered by a wild-type bacterium could induce global changes in the cell architecture to facilitate the internalization of an invasion deficient bacterium. We performed internalization assays with various ratios of a *C. jejuni* wild-type strain and the *ciaC* mutant (Figure [9](#F9){ref-type="fig"}). In this experiment, the amount of the *ciaC* mutant added to each well was kept constant while increasing amounts of the *C. jejuni* wild-type strain were added. Consistent with previous work (Christensen et al., [@B7]), a significant reduction in invasion was noted for the *C. jejuniciaC* mutant when compared to the wild-type strain. However, the number of internalized *ciaC* mutant bacteria did not change in response to additional wild-type bacteria. These results suggest that the Cia proteins act in a localized manner within the cell, and that the membrane ruffling induced by wild-type *C. jejuni* is not sufficient to facilitate the uptake of a bacterium attached to another location on the host cell.

![**Cia delivery by the *C. jejuni* F38011 wild-type strain cannot rescue the invasion of a *ciaC* mutant.** A bacterial invasion assay was performed using the *C. jejuni* F38011 wild-type strain, the isogenic *ciaC* mutant, or a mixture of both strains. The numbers of internalized *C. jejuni* F38011 wild-type (black bars) and *ciaC* mutant (white bars) bacteria were determined at 3 h post-infection using the gentamicin protection assay. The numbers below the graph indicate the quantity of *C. jejuni* F38011 wild-type and *ciaC* mutant bacteria in each well, in units of 0.03 OD~540~. The error bars represent one standard deviation. The number of *C. jejuniciaC* mutant bacteria internalized did not change in response to increasing amounts of wild-type bacteria, as judged by the Student\'s *t*-test (*P* \< 0.05).](fcimb-02-00031-g0009){#F9}

Discussion {#s4}
==========

While the precise roles of virulence proteins in facilitating bacterial invasion of host epithelial cells remain to be elucidated, it is clear that virulence proteins are secreted from the cell in a flagellar dependent manner (Konkel et al., [@B24], [@B25]; Song et al., [@B44]; Poly et al., [@B38]). While some secreted virulence proteins likely act on the surface of the cell, others are presumably delivered to the cytosol, based on their biological functions. Prior to this study, it was not known whether the Cia proteins: (1) modulate host cell activities from the extracellular environment; (2) are delivered to the cytosol of host cells from the flagellum; or (3) are exported to the extracellular environment and then taken into the cytosol via a mechanism independent of the flagellum. Although we are unable to elucidate the precise mechanism of CiaC delivery, we demonstrate that cell-associated *C. jejuni* are necessary for delivery of CiaC to the cytosol of host cells. The delivery of CiaC is dependent on a functional flagellar T3SS. The flagellar proteins FlaA, FlaG, and FlgB were not delivered to host cells, suggesting that the mechanism of delivery of some Cia proteins to a host cell is specific. The addition of cell-free supernatants containing CiaC-ACD did not result in cAMP production, indicating that CiaC is delivered by a mechanism without an extracellular intermediate.

In a previous study, it was found that inactivation of the *flaAflaB* locus in *C. jejuni* 81116 (GRK7 strain) abolished secretion of the Cia proteins (Grant et al., [@B19]). Noteworthy is that the *C. jejuni* 81116 GRK7 *flaAflaB* mutant was constructed via a different method than the *C. jejuni* F38011 *flaAflaB* mutant, such that the *C. jejuni* 81116 *flaAflaB* mutant chromosome still possessed a 5′ portion of the *flaA* gene. Surprisingly, when we completely deleted the *flaA* and *flaB* locus in the *C. jejuni* F38011 strain, the Cia proteins were still secreted. To determine whether this phenotype was strain-specific, we generated identical mutations in *C. jejuni* strains F38011, 81116, and 81--176. When the *flaAflaB* locus was completely deleted, the three mutant strains were still able to secrete the Cia proteins. Our results demonstrate that FlaA and FlaB are not required for secretion of the Cia proteins. Based on this finding, it may be useful to re-examine previous studies that have examined the role of FlaA and FlaB in motility, human disease, and commensal colonization of chickens, to ensure that the observed phenotypes are due solely to loss of motility and not loss of protein secretion through the T3SS (Grant et al., [@B19]; Konkel et al., [@B25]).

One of the first questions we sought to address in this study is whether the Cia proteins were actually delivered to the cytosol of host cells. Using the ACD reporter assay, we found that Cia secretion competent *C. jejuni* strains (i.e., *C. jejuni* F38011 wild-type, *fliD* mutant, and *flaAB* mutant) were able to deliver CiaC-ACD and CiaI-ACD to host cells, resulting in an increase in cAMP levels. *C. jejuni* strains that could not secrete the Cia proteins (i.e., *C. jejuni flgL* mutant, *flgK* mutant, and *flgE* mutant) were unable to deliver CiaC-ACD to host cells. Other proteins secreted through the flagella (i.e., FlaA, FlgB, and FlaG) are either not delivered to the host cell, or delivered in minute quantities compared to CiaC or CiaI, as the FlaA-ACD, FlgB-ACD, and FlaG-ACD proteins did not result in significant increases in cAMP. Noteworthy is that CiaI-ACD, FlaA-ACD, and FlaG-ACD were secreted from *C. jejuni* at similar levels as judged by immunoblot (Figure [A3](#FA3){ref-type="fig"}), while CiaI-ACD was the only protein delivered to host cells. While the precise mechanism of Cia delivery via the flagellum remains to be elucidated, it is clear that the Cia proteins are delivered to the cytosol of host cells.

To our knowledge, *C. jejuni* is the only organism that uses a flagellar T3SS to deliver effector proteins to the cytosol of target cells. While it had been hypothesized that the Cia proteins could be delivered to host cells via the flagellar filament, a critique of this hypothesis was the inequality of the injectisome needle and flagellar filament. The injectisome needle complex is typically ∼1 μm in length, rigid, and stationary (Sory et al., [@B45]; Cornelis, [@B9]). In contrast, the flagellar filament of *C. jejuni* can be longer than 3 μm, is flexible, and is rapidly rotating during bacterial movement (Grant et al., [@B19]). Interestingly, many components of the flagellar T3SS have orthologs in injectisome T3SS (Desvaux et al., [@B10]; Erhardt et al., [@B11]). In fact, the basal body and hook structure of the flagellum is similar in structure to the basal body and needle of the injectisome (Cornelis, [@B9]; Erhardt et al., [@B11]). This study revealed that the flagellar cap protein FliD and filament proteins FlaA and FlaB are dispensable for Cia protein secretion, while the hook protein FlgE and hook-filament junction proteins FlgK and FlgL are required. The secretion negative phenotype of the *flgK* mutant is in agreement with a previous study by Fernando et al. (Fernando et al., [@B13]). Thus, it is possible that the *C. jejuni* flagellar T3SS without a filament could function analogous to an injectisome. We hypothesize that there may be additional proteins that interact with the flagellar hook (i.e., FlgE, FlgK, and/or FlgL) to enable direct delivery of CiaC, similar to a translocon complex that interacts with the tip of the injectisome needle.

Treatment of INT 407 cells with the FAK inhibitor TAE226 inhibits *C. jejuni* internalization in a dose-dependent manner. In this study, we found that delivery of CiaC-ACD was not affected by TAE226 at concentrations that reduced invasion ∼10-fold, demonstrating that CiaC can be delivered without invasion. In the *Yersinia* Ysc T3SS, protein delivery to host cells requires intimate contact with host cells (Sory et al., [@B45]). In this study, when the bacteria-host cells contact was prevented (i.e., supernatants only or filter to block contact), no protein delivery was detected. These results suggest that the delivery of the Cia proteins from *C. jejuni* to a host cell requires intimate contact. Additionally, the results of the mixed infection internalization assay (Figure [9](#F9){ref-type="fig"}) suggest that the Cia proteins act in a localized fashion within the host cell. While these findings are in agreement with the hypothesis that the flagellar T3SS of *C. jejuni* directly delivers proteins to the host cell cytosol, they do not eliminate the possibility that the Cia proteins are exported by the flagellar T3SS and taken into the host cell indirectly by a mechanism dependent on bacteria host-cell contact. However, the finding that not all flagellar exported proteins are delivered to the host cell cytosol suggests a specific mechanism for the delivery of CiaC and CiaI by the flagellum. Regardless, identification of a flagellar-associated translocon complex is necessary to conclude that the flagellar T3SS of *C. jejuni* also functions as an injectisome.

In our current model of disease, *C. jejuni* enters the intestine where it encounters environmental stimuli (i.e., deoxycholate) that up-regulate the transcription of virulence genes, including the genes encoding the Cia proteins (Stintzi et al., [@B47]; Malik-Kale et al., [@B31]). *C. jejuni* then bind to host cells via adhesins (e.g., CadF, CapA, and FlpA) (Konkel et al., [@B23], [@B26]; Ashgar et al., [@B1]; Flanagan et al., [@B15]). The binding of *C. jejuni* to host cells allows the Cia proteins to be delivered to the host cell cytosol, where they modulate host cell signaling events (Eucker and Konkel, [@B12]). The observation that chloramphenicol reduces *C. jejuni* internalization into host cells by preventing *de novo* synthesis of the Cia proteins supports the proposal that *C. jejuni* binding to host cells via the constitutively synthesized adhesins is not sufficient for host internalization, but rather sets the stage for delivery of the Cia proteins (Konkel and Cieplak, [@B22]). Our model of Cia protein delivery is comparable to the canonical T3SS-dependent virulence strategy used by other intestinal pathogens (Gauthier and Finlay, [@B17]). Pathogens that utilize T3SS often secrete and deliver multiple proteins that contribute to the processes of colonization, invasion, modulation of immune function, cytotoxicity, and tight junction disruption (Coburn et al., [@B8]). *C. jejuni* secretes ∼18 Cia proteins, and the majority have yet to be identified and characterized. It is likely that these proteins contribute to different stages of virulence. The results of this study demonstrate for the first time that CiaC and CiaI are delivered to the cytosol of host cells, and provide a framework for the dissection of *C. jejuni* pathogenesis.
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Figure A1**Complementation of the *C. jejuni flgL* mutant with a plasmid harboring *flgL* restores the flagellar filament.** *C. jejuni* wild-type strain, the *flgL* mutant, and *flgL* mutant harboring plasmid-encoded *flgL* were examined by TEM. *C. jejuni* were spotted onto formvar coated copper grids, stained with 2% phosphotungstic acid, and visualized at 6500× magnification. The scale bar represents one micron. Figure A2***C. jejuni* 81116 and 81--176 *flaAflaB* mutants secrete the Cia proteins.** Secretion of the Cia proteins from 81116 and 81--176 wild-type strains and isogenic *flaAflaB* mutants was stimulated by incubation with 1% FBS, and the secreted proteins were analyzed by autoradiograph. Figure A3**FlaG, FlaA, FlgB, and CiaI are secreted through the flagellar T3SS.** Secretion of the FlaG-, FlaA-, FlgB-, CiaI-, and MetK-ACD fusion proteins from the *C. jejuni* wild-type strain and *flgE* mutant was examined. The *C. jejuni* strains were transformed with the various ACD plasmids, and Cia secretion was stimulated by the addition of FBS. After 3 h, the proteins in the supernatant fractions were precipitated and an immunoblot was performed using an anti-ACD **(A)** and anti-CysM **(B)** antibodies. MetK-ACD was included as a negative control, as it is not secreted from *C. jejuni*. The molecular mass of the pre-stained protein standards are listed in kDa.

###### 

**Primers used in this study**.

  **Name**   **Sequence 5′--3′**                                **Purpose**
  ---------- -------------------------------------------------- ---------------------------------------------------
  MEK2474    ATATACCGCGGTTAAGTTTATTTGTAATTCTCATTTTTTTCC         F38011 *flgL* suicide vector upstream fragment
  MEK2475    ATATAGAATTCCAAGACTTAAAAGAAATGAAGGACG               F38011 *flgL* suicide vector upstream fragment
  MEK2476    ATATACCGCGGTGCATATCAAGCTTCTCTTAAAGC                F38011 *flgL* suicide vector downstream fragment
  MEK2477    ATATAGGTACCACGCAATAAAGCTTGGTTAATAGC                F38011 *flgL* suicide vector downstream fragment
  MEK2478    ATATACCGCGGGTTCCAAAAATACCCATTATAAATCC              F38011 *flgK* suicide vector upstream fragment
  MEK2479    ATATAGAGCTCCAAGAGTTTTAGAACAAGATATAGC               F38011 *flgK* suicide vector upstream fragment
  MEK2480    ATATACCGCGGCTTACTAGGGCTTAAATCTTAAGC                F38011 *flgK* suicide vector downstream fragment
  MEK2481    ATATACTCGAGCATTAGTTTTTAATACAAGTTTTGAGC             F38011 *flgK* suicide vector downstream fragment
  MEK2466    ATATAGAGCTCCTATGATCCCATGTGCAAAACG                  F38011 *flgE* suicide vector upstream fragment
  MEK2467    ATATACCGCGGATATTGCTTTAAAAAATTTAACGCTTTGG           F38011 *flgE* suicide vector upstream fragment
  MEK2468    ATATACCGCGGTAATCCAGCTTAAACAATAATTTAAGC             F38011 *flgE* suicide vector downstream fragment
  MEK2470    ATATACTCGAGGTGGAGGTTGATTTCATTAATGC                 F38011 *flgE* suicide vector downstream fragment
  MEK1874    ATATAGAGCTCTTGTAGTGGAAAAATTTATCTTGTGG              81116 *flaAB* suicide vector upstream fragment
  MEK1875    ATATACCGCGGATAATTTCAAACTCATCCATGAGC                81116 *flaAB* suicide vector upstream fragment
  MEK1876    ATATACCGCGGTCAAGCTAACGCTGTACAGC                    81116 *flaAB* suicide vector downstream fragment
  MEK1877    ATATACTCGAGTAAAAACTTATCAAATTAATTTACATTCACC         81116 *flaAB* suicide vector downstream fragment
  MEK1866    ATATAGAGCTCAAGAAAGAGTAAATTTACAACTTAGG              81-176 *flaAB* suicide vector upstream fragment
  MEK1867    ATATACCGCGGAAATAATTTCAAACTCATCCATGAGC              81-176 *flaAB* suicide vector upstream fragment
  MEK1868    ATATACCGCGGAAACTATTACAATAATCTTTCTAAAGAGC           81-176 *flaAB* suicide vector downstream fragment
  MEK1869    ATATACTCGAGAATAATAATATAGCAGAGTTAATTTTTGG           81-176 *flaAB* suicide vector downstream fragment
  MEK2066    AAACCGCGGTATTGCGAAAACGATGAAGAAC                    Tetracycline cassette amplification
  MEK2074    AAACCGCGGGTCTCTAATCCTTTCAAATCTC                    Tetracycline cassette amplification
  MEK3030    ATATACTCGAGTATATCAAGAAATAGGTATTAACAAGC             *flgL* mutant complementation
  MEK3031    ATATAGAATTCGAAAATAAAATCAAAGCCAAATTATACC            *flgL* mutant complementation
  MEK2319    ATATAGATCTCAGCAATCGCATCAGGCTG                      Adenylate cyclase domain amplification
  MEK2382    ATATGGTACCTTATCCATAGCCGGAATCCTG                    Adenylate cyclase domain amplification
  MEK2599    CCGCTCGAGCTGCAGGAGCTCCAGCTTTTGTTCCCTTTAGTGAGG      ACD vector inverse PCR
  MEK2629    ATACTGCAGCTCGAGGGATCCGAATTCAGATCTCAGCAATCGCATCAG   ACD vector inverse PCR
  MEK2913    ATATGAGCTCTTCATTTGCTCCTTGCTTGCC                    *ciaC* ACD fusion construct
  MEK2620    ATATAGAATTCCTTTGTATTGTTTGTGGCATTTCC                *ciaC* ACD fusion construct
  MEK2740    ATATGAGCTCTTCATTTGCTCCTTGCTTGCC                    *ciaI* ACD fusion construct
  MEK2666    ATATAGAATTCGGCGTAAAGATTTAAACTATCATC                *ciaI* ACD fusion construct
  MEK2917    ATATAGAGCTCAAAGATTTTTAGACGATGCTTTAGC               *flaA* ACD fusion construct
  MEK2918    ATATAGAATTCTAAAACATTTTGTTGAACAGAATTAGC             *flaA* ACD fusion construct
  MEK2919    ATATAGAGCTCATATTTTTATCAAAGAAGAAAGACTTGG            *flaG* ACD fusion construct
  MEK2920    ATATAGAATTCACTCTCCTTATCAAATATCATTCC                *flaG* ACD fusion construct
  MEK2921    ATATAGAGCTCGGTATGAAACTTCAAATGGATGG                 *flgB* ACD fusion construct
  MEK2922    ATATAGAATTCAGAGCTTGCATCAAGTATAGAAC                 *flgB* ACD fusion construct
  MEK2931    ATATAGAGCTCAACAAGCATAGGAGCGATAGC                   *metK* ACD fusion construct
  MEK2932    ATATAGAATTCTAGCTTTTTAAACTGTTCTAGAGC                metK ACD fusion construct
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